Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Carcinogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/carcin/bgs318PMID 23054612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53, a novel regulator of lipid metabolism pathways.

  2012cited by this paper
• p53, a novel regulator of lipid metabolism pathways

  2012cited by this paper
• Regulation of lipid metabolism by p53 - fighting two villains with one sword.

  2012cited by this paper
• Genistein, Resveratrol, and 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Induce Cytochrome P450 4F2 Expression through an AMP-Activated Protein Kinase-Dependent Pathway

  2011influential reference
• Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner

  2011cited by this paper
• AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

  2011cited by this paper
• Metabolic regulation by p53

  2011cited by this paper
• ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress.

  2011cited by this paper
• Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

  2011cited by this paper
• Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro.

  2010cited by this paper
• Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass.

  2010cited by this paper
• Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.

  2009cited by this paper
• GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress.

  2009cited by this paper
• The expanding universe of p53 targets

  2009cited by this paper
• Blinded by the Light: The Growing Complexity of p53.

  2009cited by this paper
• Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

  2008cited by this paper
• Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.

  2008cited by this paper
• The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks.

  2007cited by this paper
• Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer‐binding protein β

  2007cited by this paper
• The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.

  2007influential reference
• Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism.

  2006cited by this paper
• Direct Assessment of Promoter Activity of Human Cytochrome P450 Genes Using Optimized Transfection in Vitro and in Vivo

  2006cited by this paper
• Luminogenic cytochrome P450 assays

  2006cited by this paper
• AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

  2005influential reference
• Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• The p53MH algorithm and its application in detecting p53-responsive genes

  2002cited by this paper
• Clinical importance of the cytochromes P450.

  2002cited by this paper
• Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.

  2002cited by this paper
• Quantification of doxorubicin in plasma—a comparative study of capillary and venous blood sampling

  2001cited by this paper
• Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.

  2001influential reference
• Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

  2001cited by this paper
• Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial

  2001cited by this paper
• Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

  1998cited by this paper
• Development of an in vitro reporter gene assay to assess xenobiotic induction of the human CYP3A4 gene

  1997cited by this paper
• Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.

  1993cited by this paper
• Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids

  1990cited by this paper
• Clinical kinetics on intact cisplatin and some related species.

  1981cited by this paper
• Clinical kinetics of intact cisplatin and some related species

  1981cited by this paper

• Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome– paving the path towards precision medicine: a case report

  2025cites this paper
• Advances in Cytochrome P450 in Tumor Therapy

  2025cites this paper
• CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway

  2025cites this paper
• Nanozymes expanding the boundaries of biocatalysis

  2025cites this paper
• 30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model

  2025cites this paper
• The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.

  2024cites this paper
• The p53 protein - not only the guardian of the genome.

  2024cites this paper
• Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma

  2024cites this paper
• Integrative Analysis of Histone Acetylation Regulated CYP4F12 in Esophageal Cancer Development

  2024cites this paper
• Gene expression profiling of vitamin D metabolism enzymes in leukemia and lymphoma patients: molecular aspect interplay of VDR, CYP2R1, and CYP24A1

  2024cites this paper
• Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1

  2023cites this paper
• Mechanisms of drug resistance in HCC

  2023cites this paper
• Pharmacokinetic drug–drug interactions with direct anticoagulants in the management of cancer‐associated thrombosis

  2023cites this paper
• Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma

  2022cites this paper
• Anthracycline derivatives inhibit cardiac CYP2J2.

  2022cites this paper
• Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis

  2022cites this paper
• Screening of medicinal plants for possible herb-drug interactions through modulating nuclear receptors, drug-metabolizing enzymes and transporters.

  2022cites this paper
• Expression of Cytochrome P450 Enzymes in Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Possible Role in Carcinogenesis and Treatment Response

  2022cites this paper
• A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease

  2021cites this paper
• Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes

  2021cites this paper
• Sildenafil aggravates adriamycin-induced testicular toxicity in rats; a preliminary investigation

  2021cites this paper
• Excessive ammonia inhalation causes liver damage and dysfunction by altering gene networks associated with oxidative stress and immune function.

  2021cites this paper
• Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management

  2020cites this paper
• The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes

  2020cites this paper
• Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line

  2019cites this paper
• Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?

  2019influential citation
• Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

  2019cites this paper
• Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review

  2019cites this paper
• The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

  2019cites this paper
• Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment

  2019cites this paper
• Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner

  2018cites this paper
• The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/−) and TP53(−/−) cells

  2018influential citation
• p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression

  2018cites this paper
• Simultaneous Physiologically Based Pharmacokinetic (PBPK) Modeling of Parent and Active Metabolites to Investigate Complex CYP3A4 Drug-Drug Interaction Potential: A Case Example of Midostaurin

  2018cites this paper
• The impact of p53 function on the metabolic activation of the carcinogenic air pollutant 3-nitrobenzanthrone and its metabolites 3-aminobenzanthrone and N-hydroxy-3-aminobenzanthrone in human cells

  2018cites this paper
• Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?

  2017cites this paper
• 53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice Running title : p 53 attenuates cholic acid-induced cholestasis

  2017cites this paper
• p53‐mediated regulation of bile acid disposition attenuates cholic acid‐induced cholestasis in mice

  2017cites this paper
• Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines

  2016cites this paper
• Perturbation-response genes reveal signaling footprints in cancer gene expression

  2016cites this paper
• Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin.

  2016cites this paper
• carcinogen benzo [ a ] pyrene : effects in Trp 53 ( + / + ) , Trp 53 ( + /-) and Trp 53 (-/-) mice

  2015cites this paper
• Short Report Metabolic activation of 2-amino-1-methyl-6-phenylimidazo [4,5- b ]pyridine and DNA adduct formation depends on p53: Studies in Trp53 ( 1 / 1 ), Trp53 ( 1 / 2 ) and Trp53 ( 2 / 2 ) mice

  2015cites this paper
• Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6.

  2015cites this paper
• The Molecular Pathology of Chemoresistance During the Therapeutic Response in Breast Cancer

  2015cites this paper
• Induction of Human UDP-Glucuronosyltransferase 2B7 Gene Expression by Cytotoxic Anticancer Drugs in Liver Cancer HepG2 Cells

  2015influential citation
• Recovery of adriamycin induced mitochondrial dysfunction in liver by selenium

  2015cites this paper
• Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts

  2015cites this paper
• Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation

  2015cites this paper
• The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice

  2015cites this paper
• Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer

  2015cites this paper
• Decreased elimination clearance of midazolam by doxorubicin through reductions in the metabolic activity of hepatic CYP3A in rats

  2015cites this paper
• Metabolic activation of 2‐amino‐1‐methyl‐6‐phenylimidazo [4,5‐b]pyridine and DNA adduct formation depends on p53: Studies in T rp53(+/+),T rp53(+/−) and T rp53(−/−) mice

  2015cites this paper
• Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway

  2014influential citation
• DMD059626 1698..1707

  2014cites this paper
• Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts Toxicology in Vitro

  2014cites this paper
• Characterization of the Active Site Properties of CYP4F12

  2014cites this paper
• Transcriptional regulation of human UDP-glucuronosyltransferase genes

  2014cites this paper
• Characterization of the Active Site Properties of CYP 4 F 12 s

  2014cites this paper
• Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism

  2014influential citation
• Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation

  2014cites this paper
• p53 in liver pathologies—taking the good with the bad

  2014cites this paper
• Cancer Chemotherapy: Time for New Solution

  2014cites this paper
• p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production

  2013cites this paper
• An integrated pharmacogenomic analysis of doxorubicin response using genotype information on DMET genes

  2013cites this paper
• Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

  2013cites this paper